# FDA Inspection 1044823 - Bloodworks - February 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/79e4c662-416e-428f-94ff-e3c377a05e2c
Source feed: FDA_Inspections

> FDA Inspection 1044823 for Bloodworks on February 16, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044823
- Company Name: Bloodworks
- Inspection Date: 2018-02-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1299498 - 2026-01-21](https://www.keypedia.com/records/fda_inspections/bloodworks/0fe3189a-1619-46c1-baf5-aa7f68cc69c4)
- [FDA Inspection 1299498 - 2026-01-21](https://www.keypedia.com/records/fda_inspections/bloodworks/68f915ec-1ed0-45a1-8921-329eb1239313)
- [FDA Inspection 1164283 - 2022-03-03](https://www.keypedia.com/records/fda_inspections/bloodworks/36586ba5-d104-44f5-8639-94fad05ad051)
- [FDA Inspection 1164283 - 2022-03-03](https://www.keypedia.com/records/fda_inspections/bloodworks/914efbba-ce7f-4cd3-81ea-5bb98cd8337d)
- [FDA Inspection 960793 - 2016-01-21](https://www.keypedia.com/records/fda_inspections/bloodworks/c1d115fa-e234-4fdc-b29a-dfa1f52c76c1)

Company: https://www.keypedia.com/companies/bloodworks/e403e8e1-ea83-412d-8df0-39ed1f00fc57

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d